Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

DuPont Merck reports orally active acetylcholine release enhancer

April 15, 1997

New COX-2 inhibitor from Searle

April 15, 1997

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

April 15, 1997

Melanotropic peptide effective in men with erectile dysfunction

April 15, 1997

Initial clinical results with vinpocetine for urge incontinence

April 15, 1997

Moxisylyte recommended as first-line therapy for erectile dysfunction

April 15, 1997

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Mechanism of impaired erection with finasteride elucidated

April 15, 1997

In vitro antitumor activity of lactoferrin

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...